🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Metastatic Gastrointestinal Stromal Tumor (GIST)

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline) NCT07585266Phase 393 sites📍 Scottsdale📍 San Francisco📍 New Haven GlaxoSmithKline · Tests: Velzatinib, Imatinib Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments NCT07618377Phase 12 sites📍 Kashiwa📍 Tokyo Ono Pharmaceutical Co., Ltd. · Tests: DCC-2618 Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten) NCT05009927Phase 213 sites📍 Besançon📍 Bordeaux📍 Limoges Centre Leon Berard · Tests: Imatinib tablets A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors NCT05464875n/a1 site📍 Guangzhou Xinhua Zhang, MD A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit NCT06805825Phase 15 sites📍 Ann Arbor📍 Cleveland📍 Portland Novelty Nobility, Inc. · Tests: NN3201 Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment NCT07559864Phase 21 site📍 Beijing Jian Li · Tests: physician-selected treatment, Regorafenib + Envafolimab Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study NCT07522762n/a1 site📍 Amsterdam The Netherlands Cancer Institute (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors NCT05208047Phase 3126 sites📍 Birmingham📍 Scottsdale📍 Tucson Cogent Biosciences, Inc. · Tests: CGT9486, CGT9486, Sunitinib, Sunitinib, Midazolam A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy NCT07218926Phase 3156 sites📍 Phoenix📍 Duarte📍 La Jolla GlaxoSmithKline · Tests: IDRX-42, Sunitinib A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites📍 Birmingham📍 Duarte📍 Fort Myers Bayer · Tests: BAY2927088 KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) NCT07406633Phase 217 sites📍 Los Angeles📍 Jacksonville📍 Miami Kumquat Biosciences Inc. · Tests: KQB198, Imatinib (Gleevec) Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA NCT05461664n/a1 site📍 Guangzhou Xinhua Zhang, MD A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib NCT07689201Phase 23 sites📍 Fukuoka📍 Hokkaido📍 Tokyo GlaxoSmithKline · Tests: Velzatinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy